Your browser doesn't support javascript.
loading
Response criteria for intraocular retinoblastoma: RB-RECIST.
Berry, Jesse L; Munier, Francis L; Gallie, Brenda L; Polski, Ashley; Shah, Sona; Shields, Carol L; Gombos, Dan S; Ruchalski, Kathleen; Stathopoulos, Christina; Shah, Rachana; Jubran, Rima; Kim, Jonathan W; Mruthyunjaya, Prithvi; Marr, Brian P; Wilson, Matthew W; Brennan, Rachel C; Chantada, Guillermo L; Chintagumpala, Murali M; Murphree, A Linn.
Affiliation
  • Berry JL; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Munier FL; USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
  • Gallie BL; Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Lausanne, Switzerland.
  • Polski A; Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
  • Shah S; Department of Ophthalmology & Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Shields CL; Departments of Molecular Genetics & Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Gombos DS; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Ruchalski K; USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
  • Stathopoulos C; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Shah R; USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
  • Jubran R; Ocular Oncology Service, Wills Eye Hospital, Philadelphia, Pennsylvania, USA.
  • Kim JW; Department of Head & Neck Surgery, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mruthyunjaya P; Department of Radiology, David Geffen School of Medicine at University of California, Los Angeles, California, USA.
  • Marr BP; Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Lausanne, Switzerland.
  • Wilson MW; Cancer and Blood Disease Institute at Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Brennan RC; Cancer and Blood Disease Institute at Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Chantada GL; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Chintagumpala MM; USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
  • Murphree AL; Department of Ophthalmology, Stanford Byers Eye Institute, Palo Alto, California, USA.
Pediatr Blood Cancer ; 68(5): e28964, 2021 05.
Article in En | MEDLINE | ID: mdl-33624399
Standardized guidelines for assessing tumor response to therapy are essential for designing and conducting clinical trials. The Response Evaluation Criteria In Solid Tumors (RECIST) provide radiological standards for assessment of solid tumors. However, no such guidelines exist for the evaluation of intraocular cancer, and ocular oncology clinical trials have largely relied on indirect measures of therapeutic response-such as progression-free survival-to evaluate the efficacy of treatment agents. Herein, we propose specific criteria for evaluating treatment response of retinoblastoma, the most common pediatric intraocular cancer, and emphasize a multimodal imaging approach for comprehensive assessment of retinoblastoma tumors in clinical trials.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinoblastoma / Retinal Neoplasms / Response Evaluation Criteria in Solid Tumors Type of study: Guideline Limits: Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinoblastoma / Retinal Neoplasms / Response Evaluation Criteria in Solid Tumors Type of study: Guideline Limits: Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States